Monoclonal antibodies (mAbs) have transformed modern medicine with groundbreaking treatments across a spectrum of diseases, including cancers, autoimmune conditions, and infectious diseases.

With a focus on precision and efficiency, our comprehensive suite of products and services spans monoclonal antibody discovery, development, and production. We offer advanced solutions for target identification, lead optimization, upstream and downstream processing, formulation, quality control, data analytics, and automation with integrated regulatory expertise.

Additionally, our services are designed to address your specific needs effectively and ensure compliance throughout the process. From outsourcing the development and manufacturing of your mAb therapeutic to mAb product characterization and biosafety testing, we are committed to empowering you at every stage in the development and manufacturing of monoclonal antibody therapies.